Valuation (47%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 29.00 | N/A |
PEG Ratio (TTM) | 3.39 | N/A |
P/S Ratio (TTM) | 1.66 | N/A |
P/B Ratio (TTM) | 1.68 | N/A |
P/FCF Ratio (TTM) | -17.94 | N/A |
Price to 5YR AVG Earnings Ratio | 23.84 | N/A |
Price to 5YR AVG FCF Ratio | 42.82 | N/A |
Profitability (20%) |
Company | Industry |
---|---|---|
ROA (TTM) | 0.92% | N/A |
ROE (TTM) | 5.92% | N/A |
Net Profit Margin (TTM) | 5.98% | N/A |
ROIC 5YR AVG | 7.65% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 24.72% | 204.13% | 99.59% |
Revenue | 22.65% | 37.62% | 20.86% |
Net Income | 23.99% | 201.33% | 97.25% |
Cash Flow | -342.58% | -191.14% | -153.17% |
Health (37%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.91 | N/A |
Quick Ratio (TTM) | 0.91 | N/A |
D/E Ratio (TTM) | 1.46 | N/A |
Interest Coverage (TTM) | 1.22 | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | 0.71 | N/A |
LTL to 5YR AVG FCF | 39.91 | N/A |
Shares Outstanding Growth 5YR AVG | -5.37% | N/A |